Talphera, Inc. (TLPH) vs Zhengye Biotechnology Holding Limited (ZYBT)
A side-by-side comparison of Talphera, Inc. and Zhengye Biotechnology Holding Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
TLPH
Talphera, Inc.
$1.10HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT
ZYBT
Zhengye Biotechnology Holding Limited
$1.13HealthcareDelayed quote: Oct 6, 2026, 3:03 PM EDT
Total return — TLPH vs ZYBT
growth of $100 · dividends reinvested · last 2yTLPH +87.1% (+36.8%/yr)ZYBT -75.5% (-50.5%/yr)TLPH compounded faster over this window
Log scale — wide-divergence pair
TLPH ZYBT
TLPH vs ZYBT: by the numbers
- •TLPH is the larger company ($57M vs $54M market cap).
- •Both run net losses; ZYBT's is the smaller (-59.97% vs -1507600.00% net margin).
Metrics side by side
Valuation
| Metric | TLPH | ZYBT |
|---|---|---|
| P/S ratio | 57089.56 | N/A |
| P/B ratio | 3.96 | 1.50 |
Profitability
| Metric | TLPH | ZYBT |
|---|---|---|
| Gross margin | 100.00% | 20.51% |
| Operating margin | -48157.14% | -58.66% |
| Net margin | -1507600.00% | -59.97% |
| ROE | -104.65% | -27.93% |
| ROIC | -65.20% | -17.88% |
Growth (annualized)
| Metric | TLPH | ZYBT |
|---|---|---|
| Revenue CAGR (5Y) | -79.92% | N/A |
| Total return CAGR (5Y) | -43.65% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.